FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2119674738> ?p ?o ?g. }

• W2119674738 endingPage "2027" @default.
• W2119674738 startingPage "2019" @default.
• W2119674738 abstract "Abstract Purpose: Somatostatin receptor (sst) targeting is an established method to image and treat sst-positive tumors. Particularly, neuroendocrine tumors express the receptor subtype 2 in high density, but sst1, sst3, sst4, and sst5 are also expressed to some extent in different human tumors. Currently used targeting peptides mainly have sst2 affinity. We aimed at developing (radio)peptides that bind with high affinity to all receptor subtypes. Experimental Design: Carbocyclic octapeptides were coupled with macrocyclic chelators for radiometal labeling. Affinity, internalization, and agonist potencies were determined on sst1- to sst5-expressing cell lines. Biodistribution was determined on nude mice bearing HEK-sst2 or AR4-2J and HEK-sst3 tumors. Results: High affinity to all receptor subtypes was found. YIII-KE88 showed agonistic properties at all five sst receptor subtypes as it inhibits forskolin-stimulated cyclic AMP production. Surprisingly, very low or even absent sst2 receptor internalization was found compared with currently clinically established octapeptides, whereas the sst3 internalization was very efficient. Biodistribution studies of [111In]KE88 and [67Ga]KE88/[68Ga]KE88 reflected the in vitro data. In nude mice with s.c. implanted sst2 (HEK-sst2, AR4-2J)-expressing and sst3 (HEK-sst3)-expressing tumors, high and persistent uptake was found in sst3-expressing tumors, whereas the uptake in the sst2-expressing tumors was lower and showed fast washout. The kidney uptake was high but blockable by coinjection of lysine. Conclusion: This peptide family shows pansomatostatin potency. As radiopeptides, they are the first to show a full pansomatostatin profile. Despite some drawback, they should be useful for imaging sst2-expressing tumors with short-lived radiometals, such as 68Ga, at early time points and for sst3-expressing tumors at later time points with longer-lived radiometals, such as 64Cu or 86Y." @default.
• W2119674738 created "2016-06-24" @default.
• W2119674738 creator A5013094846 @default.
• W2119674738 creator A5019869416 @default.
• W2119674738 creator A5022226042 @default.
• W2119674738 creator A5023353633 @default.
• W2119674738 creator A5035742901 @default.
• W2119674738 creator A5042102358 @default.
• W2119674738 creator A5042812084 @default.
• W2119674738 creator A5057197141 @default.
• W2119674738 creator A5057795723 @default.
• W2119674738 date "2008-04-01" @default.
• W2119674738 modified "2023-09-27" @default.
• W2119674738 title "New Pansomatostatin Ligands and Their Chelated Versions: Affinity Profile, Agonist Activity, Internalization, and Tumor Targeting" @default.
• W2119674738 cites W1539638522 @default.
• W2119674738 cites W1542709504 @default.
• W2119674738 cites W1584743295 @default.
• W2119674738 cites W1973110862 @default.
• W2119674738 cites W1973910939 @default.
• W2119674738 cites W1989927646 @default.
• W2119674738 cites W1995823770 @default.
• W2119674738 cites W2000200102 @default.
• W2119674738 cites W2001213717 @default.
• W2119674738 cites W2005674134 @default.
• W2119674738 cites W2006611896 @default.
• W2119674738 cites W2018042027 @default.
• W2119674738 cites W2038858812 @default.
• W2119674738 cites W2039816126 @default.
• W2119674738 cites W2040127137 @default.
• W2119674738 cites W2048686864 @default.
• W2119674738 cites W2057064048 @default.
• W2119674738 cites W2070403114 @default.
• W2119674738 cites W2072856911 @default.
• W2119674738 cites W2085744169 @default.
• W2119674738 cites W2085998656 @default.
• W2119674738 cites W2088147866 @default.
• W2119674738 cites W2090051214 @default.
• W2119674738 cites W2102603000 @default.
• W2119674738 cites W2108613323 @default.
• W2119674738 cites W2116290973 @default.
• W2119674738 cites W2128006663 @default.
• W2119674738 cites W2138185928 @default.
• W2119674738 doi "https://doi.org/10.1158/1078-0432.ccr-07-1687" @default.
• W2119674738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18381940" @default.
• W2119674738 hasPublicationYear "2008" @default.
• W2119674738 type Work @default.
• W2119674738 sameAs 2119674738 @default.
• W2119674738 citedByCount "67" @default.
• W2119674738 countsByYear W21196747382012 @default.
• W2119674738 countsByYear W21196747382013 @default.
• W2119674738 countsByYear W21196747382014 @default.
• W2119674738 countsByYear W21196747382015 @default.
• W2119674738 countsByYear W21196747382016 @default.
• W2119674738 countsByYear W21196747382017 @default.
• W2119674738 countsByYear W21196747382018 @default.
• W2119674738 countsByYear W21196747382019 @default.
• W2119674738 countsByYear W21196747382020 @default.
• W2119674738 countsByYear W21196747382022 @default.
• W2119674738 crossrefType "journal-article" @default.
• W2119674738 hasAuthorship W2119674738A5013094846 @default.
• W2119674738 hasAuthorship W2119674738A5019869416 @default.
• W2119674738 hasAuthorship W2119674738A5022226042 @default.
• W2119674738 hasAuthorship W2119674738A5023353633 @default.
• W2119674738 hasAuthorship W2119674738A5035742901 @default.
• W2119674738 hasAuthorship W2119674738A5042102358 @default.
• W2119674738 hasAuthorship W2119674738A5042812084 @default.
• W2119674738 hasAuthorship W2119674738A5057197141 @default.
• W2119674738 hasAuthorship W2119674738A5057795723 @default.
• W2119674738 hasBestOaLocation W21196747381 @default.
• W2119674738 hasConcept C126322002 @default.
• W2119674738 hasConcept C134018914 @default.
• W2119674738 hasConcept C139770010 @default.
• W2119674738 hasConcept C150903083 @default.
• W2119674738 hasConcept C170493617 @default.
• W2119674738 hasConcept C174510640 @default.
• W2119674738 hasConcept C185592680 @default.
• W2119674738 hasConcept C202751555 @default.
• W2119674738 hasConcept C207001950 @default.
• W2119674738 hasConcept C2776297358 @default.
• W2119674738 hasConcept C2777807558 @default.
• W2119674738 hasConcept C2778938600 @default.
• W2119674738 hasConcept C502942594 @default.
• W2119674738 hasConcept C55493867 @default.
• W2119674738 hasConcept C71924100 @default.
• W2119674738 hasConcept C80115893 @default.
• W2119674738 hasConcept C86803240 @default.
• W2119674738 hasConcept C98274493 @default.
• W2119674738 hasConceptScore W2119674738C126322002 @default.
• W2119674738 hasConceptScore W2119674738C134018914 @default.
• W2119674738 hasConceptScore W2119674738C139770010 @default.
• W2119674738 hasConceptScore W2119674738C150903083 @default.
• W2119674738 hasConceptScore W2119674738C170493617 @default.
• W2119674738 hasConceptScore W2119674738C174510640 @default.
• W2119674738 hasConceptScore W2119674738C185592680 @default.
• W2119674738 hasConceptScore W2119674738C202751555 @default.
• W2119674738 hasConceptScore W2119674738C207001950 @default.
• W2119674738 hasConceptScore W2119674738C2776297358 @default.
• W2119674738 hasConceptScore W2119674738C2777807558 @default.

• next